Download presentation
Presentation is loading. Please wait.
Published byJoel Turunen Modified over 5 years ago
1
Clinical Outcome following Autologous and Allogeneic Blood and Marrow Transplantation for Relapsed Diffuse Large-Cell Non-Hodgkin’s Lymphoma Ivan Aksentijevich, Richard J. Jones, Richard F. Ambinder, Elizabeth Garrett-Mayer, Ian W. Flinn Biology of Blood and Marrow Transplantation Volume 12, Issue 9, Pages (September 2006) DOI: /j.bbmt Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 OS after BMT for relapse DLCL.
Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions
3
Figure 2 OS after BMT for relapse DLCL according to disease sensitivity status at BMT. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions
4
Figure 3 Event-free survival after BMT for relapse DLCL according to disease sensitivity status at BMT. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions
5
Figure 4 Relapse-free survival after BMT for relapse DLCL according to disease sensitivity status at BMT. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.